These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1755947)

  • 1. Bilirubin or plasminogen--which is better in the assessment of the severity of viral hepatitis?
    Boyadjian HP
    Gastroenterol J; 1991; 51(2):56-61. PubMed ID: 1755947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen and plasminogen proactivator in liver diseases.
    Boyadjian HP; Bakalova RN
    Med Interne; 1988; 26(4):291-6. PubMed ID: 3244988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of antithrombin III, plasminogen and proactivator of plasminogen activity in viral hepatitis.
    Boyadjian HP
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(2):83-93. PubMed ID: 3168900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of separate quantitative determinations of serum bilirubin monoglucuronide and diglucronide in jaundice of diggerent etiology].
    Sorinson SN; Vanesian AS
    Ter Arkh; 1977; 49(2):67-9. PubMed ID: 860234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potential fibrinolytic activity of the blood in jaundice of parenchymal and mechanical origin].
    Boiadzhiian Kh
    Vutr Boles; 1984; 23(5):43-8. PubMed ID: 6543067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet adhesiveness to glass beads in liver disease.
    Langley PG; Hughes RD; Williams R
    Acta Haematol; 1982; 67(2):124-7. PubMed ID: 6801894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum fatty acids in viral hepatitis and jaundice of other etiology].
    Baran VM
    Sov Med; 1979 Dec; (12):33-7. PubMed ID: 531601
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum albumin and total globulin levels in common liver diseases in Accra (Ghana).
    Fenuku RI; Foli AK
    Trop Geogr Med; 1978 Mar; 30(1):87-90. PubMed ID: 209591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III in liver disorders.
    Sundar S; Mall RK; Dube B; Singh VP
    J Assoc Physicians India; 1991 Jul; 39(7):522-4. PubMed ID: 1800493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of increased plasma levels of liver-synthesized coagulation factors in liver disease.
    Arnman R; Iwarson S; Olsson R
    Scand J Gastroenterol; 1977; 12(4):387-9. PubMed ID: 882825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.
    Ito K; Niwa M; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1986 Nov; 11(5):345-52. PubMed ID: 3672563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the bilirubin fractions in the acute and chronic hepatitis and liver cirrhosis (Eberlaine's technique)].
    Sokolova GM
    Klin Med (Mosk); 1970 Jan; 48(1):96-102. PubMed ID: 5419575
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal platelet function and ultrastructure in fulminant hepatic failure.
    Rubin MH; Weston MJ; Bullock G; Roberts J; Langley PG; White YS; Williams R
    Q J Med; 1977 Jul; 46(183):339-52. PubMed ID: 918251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
    Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
    Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis.
    Hsu CY; Lin HC; Huang YH; Su CW; Lee FY; Huo TI; Lee PC; Lee JY; Lee SD
    Dig Liver Dis; 2010 Feb; 42(2):137-42. PubMed ID: 19595648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum beta 2 microglobulin in liver diseases.
    Beorchia S; Vincent C; Revillard JP; Trepo C
    Clin Chim Acta; 1981 Feb; 109(3):245-55. PubMed ID: 6164510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
    Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
    Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
    Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.